Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

874 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
What next?
Baumann M, Overgaard J. Baumann M, et al. Among authors: overgaard j. Radiother Oncol. 2014 Jan;110(1):1-2. doi: 10.1016/j.radonc.2014.02.004. Radiother Oncol. 2014. PMID: 24636157 No abstract available.
DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.
Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C. Overgaard J, et al. Among authors: overgaard m. Radiother Oncol. 2018 Apr;127(1):12-19. doi: 10.1016/j.radonc.2018.02.018. Epub 2018 Mar 6. Radiother Oncol. 2018. PMID: 29523409 Clinical Trial.
Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins.
Zukauskaite R, Hansen CR, Grau C, Samsøe E, Johansen J, Petersen JBB, Andersen E, Brink C, Overgaard J, Eriksen JG. Zukauskaite R, et al. Among authors: overgaard j. Radiother Oncol. 2018 Jan;126(1):48-55. doi: 10.1016/j.radonc.2017.11.024. Epub 2017 Dec 13. Radiother Oncol. 2018. PMID: 29248171 Clinical Trial.
Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group.
Lyhne NM, Johansen J, Kristensen CA, Andersen E, Primdahl H, Andersen LJ, Bøje CR, Jensen AR, Overgaard J. Lyhne NM, et al. Among authors: overgaard j. Radiother Oncol. 2016 Feb;118(2):257-66. doi: 10.1016/j.radonc.2016.02.006. Epub 2016 Feb 17. Radiother Oncol. 2016. PMID: 26897514
The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.
Lyhne NM, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Evensen J, Mortensen HR, Overgaard J. Lyhne NM, et al. Among authors: overgaard j. Radiother Oncol. 2015 Oct;117(1):91-8. doi: 10.1016/j.radonc.2015.07.004. Epub 2015 Aug 6. Radiother Oncol. 2015. PMID: 26255764 Clinical Trial.
Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
Bøje CR, Dalton SO, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Overgaard J. Bøje CR, et al. Among authors: overgaard j. Radiother Oncol. 2014 Jan;110(1):91-7. doi: 10.1016/j.radonc.2013.11.009. Epub 2014 Jan 8. Radiother Oncol. 2014. PMID: 24412015
Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy--results from the randomized DAHANCA 25B trial.
Lønbro S, Dalgas U, Primdahl H, Johansen J, Nielsen JL, Aagaard P, Hermann AP, Overgaard J, Overgaard K. Lønbro S, et al. Among authors: overgaard j, overgaard k. Radiother Oncol. 2013 Aug;108(2):314-9. doi: 10.1016/j.radonc.2013.07.002. Epub 2013 Aug 6. Radiother Oncol. 2013. PMID: 23932192 Clinical Trial.
Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.
Löck S, Linge A, Seidlitz A, Bandurska-Luque A, Nowak A, Gudziol V, Buchholz F, Aust DE, Baretton GB, Zöphel K, Steinbach J, Kotzerke J, Overgaard J, Zips D, Krause M, Baumann M, Troost EGC. Löck S, et al. Among authors: overgaard j. Radiother Oncol. 2019 Jun;135:43-50. doi: 10.1016/j.radonc.2019.02.020. Epub 2019 Mar 9. Radiother Oncol. 2019. PMID: 31015169 Clinical Trial.
Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance.
Tol JP, Dahele M, Gregoire V, Overgaard J, Slotman BJ, Verbakel WFAR. Tol JP, et al. Among authors: overgaard j. Radiother Oncol. 2019 Jan;130:75-81. doi: 10.1016/j.radonc.2018.10.005. Epub 2018 Oct 19. Radiother Oncol. 2019. PMID: 30348462
Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC).
Overgaard J, Alsner J. Overgaard J, et al. Radiother Oncol. 2019 Jan;130:191-192. doi: 10.1016/j.radonc.2018.08.014. Epub 2018 Sep 21. Radiother Oncol. 2019. PMID: 30249347 No abstract available.
874 results
Jump to page
Feedback